Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil G Snowise

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Medical Biography|May 7, 2021
Memorials to John Snow - Pioneer in anaesthesia and epidemiologyNeil G Snowise
Journal of Medical Biography|March 13, 2024
Memorials to Dr WG Grace - general practitioner and cricketing legendNeil G Snowise
Current Medical Research and Opinion|September 10, 2013
Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthmaNeil G Snowise, Diane Clements, Shu-Yen Ho, et al.
Respiratory Medicine|April 24, 2012
Efficacy and optimal dosing interval of the long-acting beta₂ agonist, vilanterol, in persistent asthma: a randomised trialRichard Sterling, Jessica Lim, Lucy Frith, et al.
BMJ Open Respiratory Research|September 30, 2022
Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practiceNawar Diar Bakerly, Kirill Nikitin, Neil G Snowise, et al.
Respiratory Research|May 21, 2013
Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging studyRichard M A Follows, Neil G Snowise, Shu-Yen Ho, et al.
American Journal of Rhinology & Allergy|December 15, 2010
Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adultsJohn T Given, Amarjit S Cheema, Tilman Dreykluft, et al.
Respiratory Research|October 8, 2011
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trialAshley Woodcock, Eric D Bateman, William W Busse, et al.
Respiratory Research|December 23, 2011
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaAshley Woodcock, Eugene R Bleecker, William W Busse, et al.
ERJ Open Research|June 10, 2021
INTREPID: single- <i>versus</i> multiple-inhaler triple therapy for COPD in usual clinical practiceDavid M G Halpin, Sally Worsley, Afisi S Ismaila, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Medical Biography|May 7, 2021
Memorials to John Snow - Pioneer in anaesthesia and epidemiologyNeil G Snowise
Journal of Medical Biography|March 13, 2024
Memorials to Dr WG Grace - general practitioner and cricketing legendNeil G Snowise
Current Medical Research and Opinion|September 10, 2013
Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthmaNeil G Snowise, Diane Clements, Shu-Yen Ho, et al.
Respiratory Medicine|April 24, 2012
Efficacy and optimal dosing interval of the long-acting beta₂ agonist, vilanterol, in persistent asthma: a randomised trialRichard Sterling, Jessica Lim, Lucy Frith, et al.
BMJ Open Respiratory Research|September 30, 2022
Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practiceNawar Diar Bakerly, Kirill Nikitin, Neil G Snowise, et al.
Respiratory Research|May 21, 2013
Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging studyRichard M A Follows, Neil G Snowise, Shu-Yen Ho, et al.
American Journal of Rhinology & Allergy|December 15, 2010
Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adultsJohn T Given, Amarjit S Cheema, Tilman Dreykluft, et al.
Respiratory Research|October 8, 2011
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trialAshley Woodcock, Eric D Bateman, William W Busse, et al.
Respiratory Research|December 23, 2011
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaAshley Woodcock, Eugene R Bleecker, William W Busse, et al.
ERJ Open Research|June 10, 2021
INTREPID: single- <i>versus</i> multiple-inhaler triple therapy for COPD in usual clinical practiceDavid M G Halpin, Sally Worsley, Afisi S Ismaila, et al.
Pageof 1